The new blockbuster paper by the St Gallen consortium reveals the efficiency pharmaceutical R&D. The majority of the approved drugs were sourced externally.
New study by the St Gallen consortium estimates the cost of one approved drug at $6.16 Billion. 7 of the top 16 pharma companies demonstrated negative R&D productivity.